Epiregulin as a therapeutic target in non-small-cell lung cancer
Noriaki Sunaga,1,2 Kyoichi Kaira2,31Oncology Center, Gunma University Hospital, 2Department of Medicine and Molecular Science, 3Department of Oncology Clinical Development, Gunma University Graduate School of Medicine, Gunma, JapanAbstract: Epiregulin (EREG) belongs to the ErbB family of ligands. ER...
Saved in:
Main Authors: | Sunaga N, Kaira K |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2015
|
Subjects: | |
Online Access: | https://doaj.org/article/584722e9cd264212b8c822f59bb017e2 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Non-small cell lung cancer: the era of targeted therapy
by: Antonoff MB, et al.
Published: (2012) -
Afatinib treatment in advanced non-small cell lung cancer
by: Hurwitz JL, et al.
Published: (2011) -
Targeted treatment of mutated EGFR-expressing non-small-cell lung cancer: focus on erlotinib with companion diagnostics
by: Karachaliou N, et al.
Published: (2014) -
Emerging treatment options in the management of non-small cell lung cancer
by: Filosso PL, et al.
Published: (2011) -
Pemetrexed in maintenance treatment of advanced non-squamous non-small-cell lung cancer
by: Minami S, et al.
Published: (2015)